Sacubitril-valsartan 24-26 MG 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F0R3L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,609
Award facts
- Contract value 100% obligated
- $16,608.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $16,608.97 delivery order to Amerisourcebergen Drug Corp on May 18, 2026, for Sacubitril-Valsartan 24–26 mg tablets (60-count units). The order carries an ultimate completion date of May 19, 2026, and is priced on a firm fixed-price basis with no set-aside.
Place of performance is Conshohocken, PA. Amerisourcebergen Drug Corp operates as the execution entity for DLA pharmaceutical distribution within its parent company, Cencora, Inc.
Quick answers
Who was awarded contract SPE2DR26F0R3L?
SPE2DR26F0R3L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 18, 2026.
How much is contract SPE2DR26F0R3L worth?
The government has obligated $16,609 on SPE2DR26F0R3L.
Is contract SPE2DR26F0R3L an order under another contract?
Yes. SPE2DR26F0R3L is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0R3L competed?
The extent of competition for SPE2DR26F0R3L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award